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Abstract
Background: More than 40% of adults in Sub-Saharan Africa are unaware of their HIV status. HIV self-testing (HIVST)
is a novel approach with a potential to increase uptake of HIV testing and linkage to care for people who test HIV
positive. We explored HIV stakeholder’s perceptions about factors that enable or deter the uptake of HIV self-testing
and experiences of self-testing of adult users in Africa.
Methods: This systematic review of qualitative evidence included articles on qualitative studies published or made
available between January 1998 to February 2018 on perspectives of key stakeholders, including HIV policymakers,
HIV experts, health care providers, and adult men and women (18 years and above) about factors that enable or
deter the uptake of HIV self-testing and experiences of self-testing among adult users.
We searched CINAHL, MEDLINE in Pubmed, EMBASE, AJOL, PsycINFO, Social Science Citation Index (SSCI), and Web
of Science for articles in English on HIVST with qualitative data from different African countries.
Results: In total, 258 papers were retrieved, and only nine (9) studies conducted in 5 African countries were eligible
and included in this synthesis.
Perceived facilitators of the uptake of HIVST were autonomy and self-empowerment, privacy, confidentiality,
convenience, opportunity to test, including couples HIV testing, and ease of use. The perceived barriers included
the cost of buying self-test kits, perceived unreliability of test results, low literacy, fear and anxiety of a positive test
result, and potential psychological and social harms. HIV stakeholder’s concerns about HIVST included human right
issues, lack of linkage to care, lack of face-to-face counseling, lack of regulatory and quality assurance systems, and
quality of self-test kits. Actual HIVST users expressed preference of oral-fluid self-testing because of ease of use, and
that it is less invasive and painless compared to finger-stick/whole blood-based HIV tests. Lack of clear instructions
on how to use self-test kits, and existing different products of HIVST increases rates of user errors.
Conclusions: Overcoming factors that may deter HIV testing, and HIVST, in particular, is complex and challenging,
but it has important implications for HIV stakeholders, HIVST users, and public health in general. Research is
warranted to explore the actual practices related to HIVST among different populations in Africa.
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Background
HIV is a serious public health burden in Africa, particu-
larly in sub-Saharan Africa (SSA). More than 75% of
HIV infected people are in Africa, and nearly half
(45.7%) of newly diagnosed cases of HIV among adults
are among Africans. Efforts to achieve the global target
of 95–95-95 by 2030 require increased uptake of HIV
testing as an entry point to HIV cascade [1, 2]. Many Af-
rican countries have scaled up HIV testing services,
coupled with increasingly wider availability of antiretro-
viral therapy (ART) [1]. More than 25% of adults in Af-
rica do not know their HIV status, irrespective of the
availability of a wider provision of HIV testing services,
making access to ART less successful [1, 2]. HIV Self-
Testing (HIVST) has been introduced as an innovative
tool with the potential for reaching high-risk, and hard-
to-reach- populations including young people with HIV
testing. HIVST, which does not provide a definitive diag-
nosis, enable potential users to know their serostatus.
Those with reactive self-test results need further con-
firmatory HIV testing at a health facility, following na-
tional testing algorithms [3, 4].
Currently, there are two rapid diagnostic tests for
HIVST, namely: finger prick test and oraQuick test (oral
test) [5–7]. The finger prick self-test prototype com-
prises of a bag with a test cassette, diluent vial, disinfect-
ant wipe, compression swab, lancet, sampler stick,
dressing and manufacturer’s instruction for use. In brief,
a drop of blood collected by a sampler stick is placed
into the test cassette, and two drops of diluent are added
before reading of the results after waiting for 10 min [7].
The Ora Quick® rapid HIV 1/2 antibody test (OraSure
Technologies, Bethlehem, PA, USA) is the first WHO
prequalified HIVST kit [8]. The Ora Quick® rapid HIV
1/2 antibody test is a lateral-flow, immuno-
chromatographic, second-generation, oral-fluid assay de-
tecting antibodies to HIV-1 and HIV-2. The Ora Quick
test kits consist of two pouches; one contains a diluent
tube and the second contains the test device and in-
struction for use. An oral fluid swab collected using the
flat-pad of the test devise from upper and lower gums is
placed into a pre-filled tube of reagent for 20 min before
reading the results [9, 10].
Globally, there is increasing evidence on enablers to,
and barriers for HIVST reported in the literature [11–
14]. Convenience, short testing and waiting time, priv-
acy, autonomy/sense of self-empowerment, use of oral
fluid instead of blood-samples, and, perceived control of
one’s health choices, are examples of key motivators [3,
12–14]. The easy to use procedures for collecting the
oral fluid sample and a waiting time of 20 min before
getting a result favors preference for oral fluid HIV test
[3, 12–14]. Various HIVST related barriers are reported
in the literature from studies conducted globally. Such
barriers includes lack of policies on HIVST, mispercep-
tions on quality of the self-test kits, and perceived ad-
verse effects associated with self-testing for HIV [15–
18].
For potential users who fear needle pricks for obtain-
ing a blood sample may find blood-based HIVST testing
a barrier [15, 17]. Another barrier is the cost of buying
the self-test kits. Most people in Low and Middle-
income countries (LMICs), including Africa, may not af-
ford to pay for the self-test kits, ranging from $ 4.8 to $
40 in different settings [15, 18].
Finally, inability to read among potential users may
limit the uptake of unsupervised HIVST, whereby an in-
dividual is supposed to test following the instruction for
use document while testing alone in privacy [18]. In
2016, the WHO recommended HIVST as a strategy to
increase universal coverage of HTS among high-risk and
hard-to-reach populations, but most African countries
have not introduced HIVST, because HIV policymakers
have reservations about the introduction of HIVST [4].
Key concerns frequently mentioned by HIV policy-
makers include lack of policies and regulatory systems,
quality of self-test kits, ethical and human right issues,
and knowledge gaps about HIVST [4, 8, 19]. This review
aimed to explore the existing qualitative evidence on the
factors, which may enable or deter the uptake of HIVST
among adults in Africa.
Objectives
The objectives of the systematic review of qualitative evi-
dence were to identify, assess and analyze the evidence
from qualitative studies on HIV stakeholder’s and poten-
tial adult users’ views about factors that enable or deter
the uptake of HIVST, and adult users’ experiences of
HIV self-testing in Africa.
Methods
This systematic review of qualitative evidence (i.e., quali-
tative evidence synthesis) used a methodology described
in a previous published systematic review protocol [20].
Search strategy
This review used a search strategy published previous by
the authors [20] and a summary is presented in attached
Additional file 1.
Inclusion and exclusion criteria
Studies were eligible if qualitative research methods
(interview, focus groups, observations, and review of
documents) or open-ended questions in questionnaires
were used to explore factors that enable or deter the up-
take of HIVST and testing experiences of adult users.
The populations of interest were: HIV stakeholders, such
as HIV policymakers, HIV experts, health care providers,
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and adult users of HIV self-testing. Because of language
constraints, studies not published in English were ex-
cluded. Conference abstracts were included only if they
represented original qualitative data.
Data collection
Extraction and management
A pre-designed data extraction form specifically for this
synthesis was used for data extraction (see Add-
itional file 2). We extracted themes, ideas, and categories
applicable to the synthesis objectives. The categories
originated from views of HIV stakeholder’s views about
their perceived barriers to, facilitators for the uptake of
HIVST, and HIVST experiences of adult users. We ob-
tained from the result section of each paper, the re-
searcher’s interpretations, described in the form of
themes, or ideas, or categories. We also scrutinize the
discussion sections and obtained pertinent information,
which was also supported with researcher’s interpreta-
tions. Additional information extracted was: the first au-
thor’s name; date of publication; language; country of
study; study settings; study participants; the HIVST ap-
proaches used; theoretical or conceptual frameworks
applied, and methodology of the study. Articles not
meeting eligibility criteria were excluded, and those
meeting the inclusion criteria were selected for full-text
review (Fig. 1).
Quality assessment of included qualitative studies
We used the Critical Appraisal Skills Programme
(CASP) quality assessment tool (see Table 2) to assess
the methodological quality (or limitations) of the qualita-
tive studies [28]. We conducted a pilot trial on three in-
cluded studies to assess the feasibility of the use of the
tool and to ensure the integrity of the assessment. We
acknowledge that there is no gold standard approach for
assessing the methodological quality (or limitations) of
primary qualitative studies, but agreed that the adapted
CASP checklist was a reasonable framework to assess
such limitations. One reviewer applied the appraisal
framework to each included study. A second reviewer
checked for discrepancies. Disagreements were resolved
through dialogue or by consulting a third reviewer.
The assessment of methodological quality (or limita-
tions) was not used to exclude studies but rather to
judge the relative contribution of each included study.
Fig. 1 Flow diagram through different phases of the review
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The aim was to understand how each study contributed
to the development of explanations and relationships,
and as part of the assessment of confidence in each re-
view finding.
Assessment of confidence in the review findings
We assessed each review finding from included qualita-
tive studies using the GRADE-Confidence in the Evi-
dence from Reviews of Qualitative research (GRADE-
CERQual: the certainty of qualitative evidence) approach
[29]. We used CERQual to transparently assess and de-
scribe how much confidence to place in the review find-
ings. In the CERQual approach assessment of certainty
is based on four key components:
The methodological quality of individual studies is the
extent to which there are concerns about the design or
conduct of the primary studies that contributed evidence
to an individual review finding [29–31]. The methodo-
logical limitations of the included studies contributing to
each review finding were assessed using the modified
CASP tool described above.
The coherence of the review finding is an assessment
of how clear and cogent (i.e. well supported or compel-
ling) the fit is between the underlying data from the pri-
mary studies and a review finding that synthesizes that
data [29, 30, 32]. The coherence of each review finding
was assessed by exploring to what extent clear patterns
could be identified across the data contributed by each
study. Further, we sought plausible explanations if vari-
ation across studies existed.
(i) Adequacy of the data is an overall determination of
the degree of richness and quantity of data
contributing/or supporting a review finding [29, 30,
33]. The adequacy of the data for each review
finding was assessed in terms of the “thickness” of
data, the number of studies, and the stratification of
countries and/or regions.
(ii) The relevance of included studies to the review
question is the extent to which the body of
evidence from the primary studies supporting a
review question applies to the context specified in
the review question [29, 30, 34]. The relevance of
each review finding to the research question was
assessed in terms of perspective or population, a
phenomenon of interest, settings, place,
intervention, and findings.
After assessing each of the four components, we re-
ported as having: minor, moderate, serious methodo-
logical limitations; no or very minor, moderate, serious
concerns about coherence; very thin or thin data, mod-
erate rich adequacy of data, and unclear, partial, direct
relevance. For the overall confidence, we used four levels
to indicate the confidence of the qualitative evidence:
high, moderate, low, and very low [29, 30]. Our judg-
ments were based on an initial assumption that all re-
view findings were ‘high confidence' and then
downgraded by one, two, or three levels if there were
important rather than minor concerns regarding any of
the four CERQual components. The key findings, the
confidence of evidence for each finding, and an explan-
ation of the assessment of the certainty of the qualitative
evidence are presented in a summary table [28].
Analysis and synthesis process
We conducted thematic synthesis for enablers of, and
deterrents to the uptake of HIVST, and HIV self-testing
experiences, using framework analysis [35–39]. The the-
matic analysis suit studies with a priori aims and objec-
tives designed to directly inform policy and practice.
The thematic synthesis aimed to enhance understanding
of questions regarding: ‘what works for whom and in
what context’, and to identify ‘barriers’ and ‘facilitators’
to the uptake of HIVST. We ‘pooled’ the results from in-
dividual primary studies by initially separating the find-
ings, interpreting and then combining all through the
identification of key themes across studies [38, 39].
Two reviewers independently coded key descriptive
themes on HIV self-test experiences, enablers of, and de-
terrents to the uptake of HIVST. We discussed the
resulting themes and sub-themes within the study team
as analysis progressed to examine their relationship to
the synthesis outcomes. The basic units of the review
were elements of the texts reported in the ‘result’ section
of each primary study included in the analysis. The text
from each primary study was extracted verbatim and en-
tered into a spreadsheet.
Familiarisation with the dataset included reading and
rereading the textual data. Sections of the text were
coded, with multiple codes being allocated where appro-
priate. The qualitative synthesis then proceeded by using
the ‘descriptive themes’ to develop ‘analytical themes’,
which were interpreted about the synthesis aims. During
the analysis, differences or similarities were identified
within emerging themes [38, 39].
This qualitative synthesis of evidence is reported fol-
lowing the ENTREQ statement guidelines to ensure
transparency (see Additional file 3: Table S3.) [21].
Ethical considerations
This study did not undertake any formal data collection
involving any humans or animals.
Results
Database search
A total of 258 papers were found across the three data-
bases. After excluding duplicates, 232 articles remained.
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Out of these, 174 were excluded based on title or ab-
stract was deemed to hold no relevance to the current
synthesis based on the inclusion and exclusion criteria.
We retrieved full text for the remaining 58 articles. Out
of 58 full-text articles assessed for eligibility, 49 articles
were excluded due to: ‘outcome not of interest’ (n = 22),
‘unclear study design’ (n = 18), and ‘participant not of
interest ’ (n = 9). Nine (9) studies met the inclusion cri-
teria and are included in this synthesis (see Fig. 1).
Study characteristics
The nine (9) studies, including 397 participants included
in this synthesis were conducted in five (5) countries,
namely in Malawi, South Africa, Tanzania, Kenya, and
Zimbabwe. The studies were conducted in 2011 (n = 1);
2013 (n = 3); 2015 (n = 2); 2016 (n = 2), and 2017(n = 1).
Most studies used a mixed-sex sample (n = 6), female
only (n = 2), and male-only (n = 1). Studies were con-
ducted with actual HIVST users (adult men and women
in the general population; n = 2), potential HIVST users
(adult men and women in the general population; n = 3),
HIV stakeholders (e.g. HIV experts, HIV policymakers,
researchers, ethicists, etc.) and health care providers,
(n = 3), and pregnant women attending antenatal clinic,
and their male partners (n = 1). All of the included stud-
ies were published in peer-reviewed journals. In general,
studies gave some description of the strategies they had
used to select participants and to collect and analyze
data, although these descriptions tended to be brief
(Table 1).
Quality assessment of included qualitative studies
The quality assessment of included studies was using
standardized criteria based on the CASP tool, which ex-
amined 10 criterions. Study quality was scored according
to the CASP critical score as follows: If the criterion was
completely met = 2 points; criterion partially met = 1
point; and criterion not applicable/ unmet/not men-
tioned = 0. Finally, the study quality was classified ac-
cordingly: A total score of 20 = high quality; 16–19 =
moderate quality; and ≤ 15 = low quality. None of the
study findings were assessed to be of high quality, be-
cause of a lack of information regarding the relationship
between researchers and participants. All nine studies
were categorized as moderate quality (total score = 18–
19). See Table 2.
All of the included studies gave a clear statement of
the aims of their research, using either in-depth inter-
views and/ or focus group discussions. None of the stud-
ies used long-term ethnographic research. Furthermore,
none of the included studies discuss reflexivity (i.e. con-
sideration of the relationship between the researchers,
participants, and study settings). Most of the included
studies had a description of data analysis, using different
analysis strategies, such as descriptive or exploratory ap-
proaches. Most of the included studies had their findings
supported by the data, except for one study with a rela-
tively short description of the preference of HIVST
among study participants. The general lack of ‘thick de-
scription’ may have been due to the study aims, or
choice of methods in which the studies were conducted.
Confidence in the findings of the review
As described in the methods section, we used the
CERQual approach to assess the confidence of each re-
view finding, grading each finding as either of high,
moderate or low confidence. We assessed most of the
findings as of moderate confidence because of the meth-
odological limitations of the underlying studies. We
assessed one study to be of low confidence because of
concerns regarding both methodological limitations and
adequacy with limited data. In this review, twenty-one
(21) statements were generated and summarized into
four (4) themes: potential facilitators of HIVST per-
ceived barriers to HIVST, concerns about HIVST, and
HIVST experiences. The confidences in the findings of
the review are summarized in Table 3.
Potential facilitators of HIVST
Availability of HIVST
The availability of HIVST was perceived by HIV experts,
HIV policymakers, and health care providers as a factor
that would increase uptake of HIV testing, enable repeat
testing, identifying first-time testers, and early diagnosis,
leading to the linkage of care and treatment.
“We need to look at all avenues so that people can
access testing services at the moment [... .], we think
that the availability of self-testing in this country is
going to help us to achieve that target (80%), [... .].
The more clients repeat testing the more we can
identify first-time testers, and early diagnosis, and
more we can link to care and treatment. “ [HIV
policymaker] [22].
Stigma and discrimination associated with HIV testing
Furthermore, potential HIVST users identified the po-
tential of HIVST to decrease stigma and discrimination
associated with HIV testing, which will motivate men to
uptake HIVST: Men would accept [...] they would say,
“aaah, why should the doctor test me? Aaah, it’s better to
be the first to know my HIV status.” You would feel shy
when meeting the doctor who knows that you are HIV
positive [Male, IDI] [23].
Most participants agreed that HIVST provides an op-
portunity to test for HIV and to circumvent facility-
based barriers, leading to increased uptake of self-
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Women (n = 150) aged
18 years and older
Pictorial instructions, simple
sample collection with integrated
test components, and easy steps
for interpretation of results may
facilitate usability of HIVST.
Njau et al.,
(2011) [15]
Tanzania To identify characteristics of HIV
testing options associated with





a note based approach.
Men (n = 18) and
Women (n = 22) aged
18 years and older.
Self-test for HIV was perceived less
feasible for scale-up due to the un-
familiarity of HIVST; lack of counsel-
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HIV policy makers, HIV
experts, and health
care providers (n = 54).
HIVST is an important
complementary approach to
existing conventional HIV testing
services; contextual and
operational evidence needed to




Malawi To explore views regarding the
acceptability of offering HIV-self
test kits alone or in combination
with linkage intervention to ANC







Men (n = 28) and
Pregnant women (n =
34) aged 18 years and
older attending ANC
Perceived highly acceptability of
woman-delivered HIVST among
pregnant women attending ANC
and their male partners; HIVST was
not likely to lead to adverse events
(i.e., IPV); conditional financial in-
centives may motivate male part-







To explore attitudes, opinions, and
experiences among key

















Tanzania To assess perceived cost
advantages and disadvantages of
using HIVST kits among infrequent





Men (n = 23) aged 15
years and older
Financial gains and losses
influence men’s decision process
to HIVST; low fees or free HIVST,
reduced travel time, clinical costs,
and, time lost from earning





Malawi To explore factors shaping the
decision-making of cohabiting





Men (n = 17), and
Women (n = 17) aged
18 years and older
Gender roles and relationship
dynamics may influence the
implementation of community-





To assess the perceived usability
and acceptability of HIVST among





Men (n = 23) and
Women (n = 27) lay
users aged 18 years
and older in rural and
peri-urban settings.
Perceived highly acceptability and
readiness in the context of
prototypes influenced by usability
and perceived needs. Perceived
easiness-to-use, privacy, autonomy,
ease access, widespread availability
of test kits, low or free kits,








To identify young people’s
preferences for HIV-self-testing
(HIVST) delivery, determine the
relative strength of preferences,






Men (n = 54) and
Women (n = 68) aged
16–25 years old.
Young people believe that home-
based distribution of low price
self-test kits may optimize HIVST
services.
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testing: Others have said it [HIVST] will alleviate the
facility-related barriers-long waiting time, long queues,
visibility by going to a centre or a mobile clinic. [Health
care provider] [24].
HIVST and confidentiality of HIV test results
The possibility of HIVST to increase the confidentiality
of HIV test results compared to conventional HIV test-
ing approaches (i.e., voluntary counseling and testing,
provider-initiated counseling and testing, mobile coun-
seling and testing, etc.) were cited by participants.
“So I think the benefits of HIVST are pure
confidentiality, if I can own the process myself, you
know I would have that confidential aspect of HIV test
results … ” [HIV policy maker] [24].
Perceived autonomy and self-empowerment
HIV experts, HIV policymakers, health care pro-
viders, and potential HIVST users perceived that the
autonomy to make one’s own choice of HIV testing
method and self- empowerment to take responsibility
of one’s life, including sexual health is a potential fa-
cilitator to the uptake of HIVST. They believed that
the perceived autonomy and self-empowerment
would create a more active role of an individual in
managing own health and decision-making process
for HIV testing:
” … the self- empowerment to take responsibility for
my life because if I can go as far as to decide that:
“You know what, I need to be testing myself at this
level”, it means I am taking responsibility for my
sexual health, [. .] [and] I am going to think about it
in light of how I manage my life [HIV expert] [24].
Perceived convenience of self-testing
Further, the convenience of self-testing (i.e., at home
and/or any private place) in privacy was perceived as a
potential facilitator. Participants believed that HIVST
brings testing services closer to users, and would attenu-
ate traveling costs, waiting time at health facilities, and
save time for other income-generating activities, which
will encourage uptake of HIV testing.
As a 28-year-old male participant explained:
“It is different from making the process of going to the
clinic. Therefore, the number of people going to the clinic
will decrease. And your daily budget, which you reserve,
you will be able to buy the instrument because when you
go to test at the clinic you incur costs like bus fare, eating
and staying in queues. So those costs are reduced a bit “
[28- year-old men, Non-tester] [25].
Couple’ HIVST and disclosure of HIV serostatus
HIV policymakers felt that HIVST may provide an oppor-
tunity for couple’s to talk before performing self-testing.
They believed the face-to-face communication could fa-
cilitate the disclosure of HIV serostatus, and hence reduce
gender-based violence related to HIV positive results.
“[.. .] I see (HIVST) increasing couples’ talking, and in
a way, we would probably reduce GBV [gender-based
violence] because sometimes that’s the problem. When
one goes for a test and the other doesn’t know and
then the other one does find out, it is always
detrimental” [HIV policy maker] [22].
Potential barriers to HIVST
Affordability of self-test kits kits
Affordability of self-test kits was a recurring theme
across the studies in this review. Potential HIVST users
Table 2 CASP critical appraisal of studies included in this review (n = 9)
1stAuthor(year of study) CASP criterion a
1 2 3 4 5 6 7 8 9 10 Total Score b
Peck et al.,(2013) [5] 2 2 2 2 2 1 2 2 2 2 19
Njau et al., (2011) [15] 2 2 2 2 2 1 2 2 2 1 18
vanRooyen et al.,(2015) [21] 2 2 2 2 2 1 2 2 2 2 19
Choko et al., (2016) [22] 2 2 2 2 2 1 2 2 2 2 19
Makusha et al., (2013) [23] 2 2 2 2 2 1 2 2 2 2 19
Jennings et al., (2015) [24] 2 2 2 2 2 1 2 2 2 2 19
Kumwenda et al.,(2013) [25] 2 2 2 2 2 1 2 2 2 2 19
Knight et al.(2017) [26] 2 2 2 2 1 2 2 2 2 2 19
Indravudh et al., (2016) [27] 2 2 2 2 2 1 2 2 2 2 19
aCASP criterion: 1. Was there a clear statement of the aims of the research? 2. Is a qualitative methodology appropriate? 3. Was the research design appropriate to
address the aims of the research? 4. Was the recruitment strategy appropriate to the aims of the research? 5. Was the data collected in a way that addressed the
research issue? 6. Has the relationship between researcher and participants been adequately considered? 7. Have ethical issues been taken into consideration? 8.
Was the data analysis sufficiently rigorous? 9. Is there a clear statement of findings? 10. How valuable is the research?bCASP critical score: a) Criterion is completely
met = 2; b) criterion is partially met = 1; c) criterion not applicable, not met, or not mentioned = 0; Total score 20 = high quality; 16–19 moderate quality; ≤ 15
low quality
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Table 3 CERQual evidence profile
Summary of review findings Methodological
limitationsa








Potential facilitators of HIVST
1. HIV experts, HIV policymakers,
and health care providers felt
that the availability of HIVST
would increase uptake of HIV
testing, repeat testing,
identifying first-time testers, and
early diagnosis, leading to de-
creased HIV transmission in the
general population [21, 23].
Minor methodological
limitations (2 studies










adequacy of data (2
studies offering thin data
contributing to the review
finding).
High relevance (2 studies among
HIV experts and HIV stakeholders
from Kenya, Malawi, and South









concerns about adequacy of
data.
2. HIV experts, HIV policy makers,
health care providers, and
potential HIVST users identified
the potential of HIVST to
decreased stigma and
discrimination associated with
HIV testing, and increase their
motivation and uptake of self-




with unclear evidence of











adequacy of data (6
studies offering adequately
rich data contributing to
the review finding).
High relevance (6 studies among
HIV experts, HIV stakeholders, and
potential HIVST users from
Tanzania, South Africa, Malawi,
and Kenya with direct relevance
to the review question).
Moderate
confidence





3. HIV experts, HIV policy makers,
health care providers, and
potential HIVST users felt that
HIVST will provide an
opportunity to test for HIV
which will circumvent facility-
based barriers, leading to in-

















adequacy of data (6studies
offering adequately rich
data contributing to the
review finding).
High relevance (6 studies among
HIV experts, HIV stakeholders, and
potential HIVST from Tanzania,
South Africa, Malawi, and Kenya









4. HIV experts, HIV policy makers,
health care providers, and
potential HIVST users felt that
self-testing in private would in-





with unclear evidence of











adequacy of data (5
studies offering adequately
rich data contributing to
the review finding).
High relevance (5 studies among
HIV experts, HIV stakeholders, and
potential HIVST from Malawi,
Zimbabwe, Tanzania, and South








relevance, and no concerns
about adequacy of data.
5. The autonomy to make one’s
own choice of HIV testing and
self-empowerment to take re-
sponsibility for HIV testing was
perceived by HIV experts, HIV
policy makers, health care pro-
viders, and potential HIVST users
as creating a more active role in
the decision-making process for




with unclear evidence of











adequacy of data (6
studies offering adequately
rich data contributing to
the review finding).
High relevance (6 studies among
HIV experts, HIV stakeholders, and
potential HIVST from Malawi,
Zimbabwe, Tanzania, and South








relevance, and no concerns
about, adequacy of data.
6. Awareness of self-testing was
perceived by HIV experts, HIV
policy makers, health care pro-
viders, and potential HIVST users
to be facilitated through educa-
tional campaigns to the general
public using clear information
about benefits of HIVST, accom-
panied by post-testing counsel-
ing using advanced technology

















adequacy of data (6
studies offering adequately
rich data contributing to
the review finding).
High relevance (6 studies among
HIV experts, HIV stakeholders, and
potential HIVST from Malawi,
Zimbabwe, Tanzania, and South








relevance, and no concerns
about adequacy of data.
7. HIV experts, HIV policy makers,
health care providers, and
potential HIVST users reported
that the convenience of self-
testing in privacy brings testing
services closer to users. They be-
lieved this would attenuate trav-
eling costs, waiting time, and





with unclear evidence of











adequacy of data (5
studies offering adequately
rich data contributing to
the review finding).
High relevance (5 studies among
HIV experts, HIV stakeholders, and
potential HIVST from Malawi,
Zimbabwe, Tanzania, and South








relevance, and no concerns
about adequacy of data.
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Table 3 CERQual evidence profile (Continued)
Summary of review findings Methodological
limitationsa








8. Potential HIVST users believed
that HIVST might increase the
couple’s HIV testing through
face-to-face communication,
that could facilitate the disclos-
ure of HIV serostatus, and may
reduce gender-based violence














adequacy of data (2
studies offering thin data
contributing to the review
finding).
Minor concerns about relevance
(2 studies among potential HIVST
users from Malawi with partial








concern about adequacy of
data, and minor concerns
about relevance.
Potential barriers to HIVST:
9. Potential HIVST users
perceived that they might fail to
afford HIVST kits because of
concerns about the cost of














adequacy of data (3
studies offering
moderately rich data
contributing to the review
finding).
Minor concerns about relevance
(3 studies among potential HIVST
users from Malawi, Zimbabwe,
Tanzania, and South Africa with




The 3 studies of moderate
quality, with minor
methodological limitations,
high coherence, and minor
concerns about adequacy of
data and relevance.
10. HIV experts, HIV policymakers,
and health care providers
believed that the type of
distribution points for delivery of
self-test kits might hinder the
uptake of HIVST kits. Having a
variety of distribution points for
delivery of self-test kits that
would ensure privacy and confi-
dentiality were perceived to in-














adequacy of data (2
studies offering thin data
contributing to the review
finding).
High relevance (2 studies among
HIV experts and HIV stakeholders
from Kenya, Malawi, and South









concerns about adequacy of
data.
11. Some potential HIVST users
perceived that the inability of
potential clients to read,
particularly in rural settings,














adequacy of data (1 study
offering very thin data
contributing to the review
finding).
Minor concerns about relevance
(1 study among potential HIVST
users from Tanzania with partial









concerns about adequacy of
data.
12. The fear and anxiety of
receiving a positive test result
were perceived by potential
HIVST users as a barrier to
uptake of HIVST kits. Buying
HIVST kits was compared with
buying death or poison for
committing suicide [24].
Minor methodological








adequacy of data (1 study
offering moderately rich
data contributing to the
review finding).
Minor concerns about relevance
(1 study among potential HIVST
users from Tanzania with partial




One study of moderate quality,
with minor methodological
limitations, unclear coherence,
high relevance, and minor
concerns about adequacy.
13. Potential HIVST users were
concerned that the oral-fluid
self-test kits may fail to accur-
ately test for HIV because they
believed HIV is present in the
blood only. Some potential
HIVST users expressed their fear
about misinterpretation of the




limitation (3 studies with
unclear evidence of











adequacy of data (1 study
offering thin data, and 3
studies offering adequately
rich data contributing to
the review finding).
Minor concerns about relevance
(4 studies among potential HIVST
users from Tanzania, Kenya,
Malawi, and South Africa with








relevance, and minor concerns
about adequacy.
Concerns about HIVST:
14. HIV experts, HIV policymakers,
and health care providers
expressed concerns about
human rights issues related to
HIVST. They believed that HIVST
was ethical as it provides more
freedom, choices and options,
and power to individuals to test
for HIV. However, some HIV
experts cautioned that HIVST
might be unethical if it increases
vulnerabilities such as forced or
Minor methodological
limitations (2 studies










adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
HIV experts and HIV stakeholders
from Kenya, Malawi, and South








relevance, and minor concerns
about adequacy of data.
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Table 3 CERQual evidence profile (Continued)
Summary of review findings Methodological
limitationsa








coerced testing [21, 23].
15. HIV experts, HIV policymakers,
and health care providers
believed that linkage of care
was an important component
and inextricably linked to pre
and post-test counseling. They
also pointed out that a follow-
up confirmatory laboratory test
after a positive self-test might
facilitate linkage to HIV care,





with unclear evidence of











adequacy of data (5
studies offering adequately
rich data contributing to
the review finding).
High relevance (5 studies among
HIV experts and HIV stakeholders
from Malawi, Zimbabwe,
Tanzania, Kenya, and South Africa








relevance, and no concerns
about adequacy of data.
16. HIV experts, HIV policymakers,
and health care providers
expressed concerns about the
absence of face-to-face HIV
counseling. Lack of counseling
was perceived as a key limita-
tion of HIVST and may increase
the risk of psychopathic tenden-














adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
HIV experts and HIV stakeholders
from South Africa, Kenya, and








relevance, and minor concerns
about adequacy of data.
17. Lack of effective regulation of
medicines and laboratory test
such as rapid HIV tests was
perceived by HIV experts, HIV
policymakers, and health care
providers, as a major concern
about quality assurance for
HIVST kits. They believed that
state regulation was an essential
requirement to achieve quality
assurance and protect users














adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
HIV experts and HIV stakeholders
from South Africa, Kenya, and








relevance, and minor concerns
about adequacy of data.
18. HIV experts, HIV policy
makers, health care providers,
and potential HIVST users
expressed fear of low quality of
HIVST kits, because of their
previous experiences with fake
medical equipment, and false
advertisements because of a
lack of or poor quality assurance




with unclear evidence of











adequacy of data (1 study
offering thin data, and 2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (4 studies among
HIV experts, HIV stakeholders and
potential HIVST users from
Malawi, Zimbabwe, Tanzania, and
South Africa with direct relevance
to the review question).
Moderate
confidence





concerns about adequacy of
data.
HIV Self-testing experiences:
19. Some HIVST users believed
that HIVST creates an
opportunity for previous ART
users to re-start treatment, after
stopping using ART because of
the negative attitudes of some
health care providers [5, 25].
Minor methodological
limitations (2 studies










adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
actual HIVST users from Malawi,
Kenya, and South Africa with








relevance, and minor concerns
about adequacy of data.
20. Most HIVST users felt self-test
kits were easy to use, with most
preferring oral-fluid based tests
to finger stick/whole blood-
based tests because they do not
use a needle prick [5, 25].
Minor methodological
limitations (2 studies










adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
actual HIVST users from Malawi,
Kenya, and South Africa with








relevance, and minor concerns
about adequacy of data.
21. Some HIVST users expressed
confusion about how to use the
self-test kits because of the lack
of clear instructions on some
steps on how to use the kits,
leading to user errors and poor
Minor methodological
limitations (2 studies









adequacy of data (2
studies offering
moderately rich data
contributing to the review
finding).
High relevance (2 studies among
actual HIVST users from Malawi,
Kenya, and South Africa with








relevance, and minor concerns
about adequacy of data.
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mentioned that the high cost of buying self-testing kits
might deter the uptake of HIV testing.
As a 28-year-old male participant explained:
“That's why I said that if it is sold at a lower price like
from 15,000 to 20,000 [Tanzanian shillings ~$6.91 to
$9.20] people will be able to buy it. But, if it will be sold
at a higher price like at 30,000 to 40,000[Tanzanian
shillings~$13.80 to $18.40], others will fail to buy it – as
someone may have the ability to buy it, but says why
should I buy it? But at a lower price, a person can buy it
” [28-year-old-men, Non-tester] [25].
Perceived unreliability of self-test results
There was a commonly discussed belief among potential
HIVST users on the unreliability of self-test results.
They expressed their fear that the self-test kits may fail
to accurately test for HIV. This fear was based on their
misconceptions about the presence of HIV in the blood
sample, and the misinterpretation of results when testing
alone.
“So many people are not going for HIV test not
because of the fear of the unknown but the fear that
self-testing may fail to test accurately for HIV. Many
people believe that HIV is in the blood … so taking a
sample from the mouth to test for HIV and not a blood
sample is the main reason for the fear”[Female Non-
tester, IDI] [16].
Low literacy and HIVST
Concern about low literacy particularly among people
residing in rural settings was perceived as a potential
barrier. Potential HIVST users believed that the inability
to read might negatively influence the uptake of HIVST.
“Most people, particularly in the rural areas are
illiterate; they can’t read even a newspaper. How can
they be able to read and follow the instructions of how to
use the HIV self- testing kits?” [Male tester, IDI] [16].
Fear of a positive test result
One recurring theme across studies included in this syn-
thesis was the fear and anxiety of receiving a positive test
result. For example, buying of self-test kits was com-
pared with buying death or committing suicide. As a 26-
year-old male participant explained:
“It is similar to buying death. It is like someone going
to buy poison for committing suicide! So, I do not know
whether the poison is right or wrong. The point of
buying it is, like I said, buying my death. I mean just
do not sell it. As none will buy it. If it is sold, it will be
hard for someone to decide to go buy it. Trust me. You
will go buy your death, I tell you” [26-year-old-men,
Non-tester] [25].
Concerns about HIVST
HIV experts, HIV policymakers, health care providers,
and potential HIVST users expressed concerns related
to HIVST. Such concerns include human rights issues,
lack of linkage to HIV care, and treatment, lack of face-
to-face counseling, lack of regulatory and quality assur-
ance systems, and quality of self-test kits.
Human rights issues
Human rights issues reported by most participants were
based on how ethical is HIVST. Most participants con-
sidered HIVST ethical if it would provide more freedom,
choices, and options, and empower individuals to test
for HIV. However, HIVST may be unethical if it will in-
crease HIVST users vulnerabilities (i.e., coerced or
forced) testing, or used to limit their freedom and rights.
“[ … ] I can see lots of reluctance on the part of
human rights people [...] It’s more the human rights
people, an instinct around coerced or forced testing. It’s
Table 3 CERQual evidence profile (Continued)
Summary of review findings Methodological
limitationsa








accuracy of test results [5, 25]. data).
A summary of the review findings from the qualitative synthesis are presented here, with the relevant studies contributing to each review finding. The confidence in the evidence refers to
the overall CERQual assessment of methodological limitations of included studies, relevance, adequacy, and coherence, and is rated as high, moderate, or low. The explanation of the
assessment of the confidence in the evidence provides a brief assessment of each CERQual domain to support the overall CERQual assessment
a When assessing methodological limitations, we consider: the 10 CASP criterion to elucidate minor/moderate/serious methodological limitations
b When assessing coherence, we consider: clear and consistent patterns across primary studies and the review finding, and/or convincing explanations for the patterns of evidence in the
underlying studies, and for existing variation across studies to elucidate no or very minor/moderate/serious coherence
c When assessing adequacy of data, we consider: thickness of data, the number of studies, types/ number of participants, types/range of methods used across individual studies, stratification
of countries and /or regions to elucidate thin / moderate/ very rich adequacy of data
d When assessing relevance, we consider: phenomenon of interest, population, setting, place, intervention, and findings to elucidate partial/ indirect/unsure relevance
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always about protecting the tiny percentage of people
who are going to be abused.” [HIV policymaker, South
Africa] [22].
Lack of linkage to HIV care and treatment
Another major concern expressed by HIV experts,
HIV policymakers, and health care providers was the
lack of linkage to HIV care and treatment following a
positive HIV result. They generally agreed that link-
age to HIV care, and treatment, is an important com-
ponent of HIVST and inextricably linked to
counseling.
Additionally, they argued that HIVST should be
regarded as a screening rather than a testing tool and
put emphasis that a positive result needs to be
followed by a confirmatory laboratory test at the
health facility, which might facilitate linkage to HIV
care, and treatment. “[.. .], there need to be clear in-
structions on how to get into care, what needs to be
done if you test positive and if there could be a reli-
able helpline to call, that would be ideal so that
people could seek confirmatory laboratory test at the
health facility … [HIV expert] [22].
Lack of face-to-face counseling
Another concern about HIVST expressed by most par-
ticipants was the lack of face-to-face counseling. They
viewed counseling an essential component, which is
missing in HIVST. From their perspective, lack of face-
to-face counseling may increase the risk of psychopathic
tendencies, suicidal ideation, and coercion:
“Without adequate pre & post-test counseling, a react-
ive self-test result can lead to suicides, or murder,
while some psychopaths may decide to embark on a
‘revenge' vendetta by hiding their status and seeking
opportunities for unprotected sex. Also, a negative re-
sult may encourage the individual to engage in irre-
sponsible sexual activities” [HIV policy maker] [24].
Lack of effective regulation of HIVST
HIV experts, HIV policymakers, and health care pro-
viders perceived that lack of effective regulation of medi-
cines and laboratory tests might jeopardize the uptake of
HIVST because it would affect the quality assurance for
self-test kits. Most agreed that regulatory and a quality
assurance framework was essential for the uptake of
HIVST.
[ … ] several issues in terms of laws and policies on
medicines and related medical supplies need to be
addressed. [HIV expert] [24].
Perception about the low quality of self-test kits
Beliefs about individual perceptions, and previous expe-
riences with fake medical equipment or low quality of
self-test kits, and false advertisements were perceived as
a major concern in this study. Most participants
expressed their fear of the low quality of self-test kits
and false advertisements because of lack of poor quality
assurance measures, which might undermine the uptake
of HIVST:
[ … ] How will we ensure quality assurance and
ensure that the manufacturers are not false
advertising? How will we ensure that the self-tests are
manufactured by an accredited facility? All these is-
sues need to be addressed to provide a good regulatory
system” [HIV policy maker] [24].
HIV self-testing experiences
HIV self-test users believed that the availability of
HIVST creates an opportunity for previous ART users
to re-start treatment [40].
As explained by a female HIV positive participant:
“I was on ARVs[...], but[...] I stopped[....] I wanted to
start again but was shouted at the hospital because I
did not remember my number. This [HIVST] was a
better way of re-starting taking ARVs” [Female, HIV
positive, Discordant] [40].
HIV self-test users believed that uptake of HIVST
could be influenced by the ease of use of self-testing
kits particularly with oral fluid-based HIV compared
to finger stick/ whole blood-based HIV testing. Fur-
ther, most users expressed preference of oral fluid-
based HIV to finger stick/whole blood-based HIV.
While most users reported ease of use of self-test
kits, user errors are not uncommon among self-
testers. Few reported confusion on how to use self-
test kits, because of lacking clear instructions on
some steps on how to use the kits.“[The step] was a
bit confusing, because at first, I didn't know if I
should remove it [cap] on the test or pour over it.
No instructions were available for that step. Even
the picture doesn’t show.” [Male tester, South
Africa] [6].
Finally, some self-testers reported their concern about
the misinterpretation of test results because of different
products of HIVST with different instructions on how to
interpret results to increase rates of wrong interpreta-
tions of test results.
As explained by a female HIVST user:
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“Firstly we all know that if there are two lines it
means it is positive so here there are two lines and
they say it is invalid, for a villager they cannot
understand this, it doesn't matter where the lines are
but as long as there are two lines to many positive
people, so they better look into that.” [Female tester,
Malawi] [6].
Discussion
Overall, this synthesis highlighted a broad range of
qualitative evidence on potential facilitators for and per-
ceived barriers of uptake of HIVST from HIV experts,
HIV policy-makers, health care providers, and self-
testing experiences of adult users in Africa.
The findings of this synthesis are important for under-
standing the wider array of factors that may enable or
deter the uptake of HIVST, and HIVST experiences of
adult users in Africa, and how they could be integrated
into the broader HIV testing services. Our findings have
implications for future studies assessing the feasibility of
HIVST in Africa and provide valuable information for
HIV stakeholders, and interventionists to consider as
they develop policy, and/ or evaluate HIVST
interventions.
Commonly cited potential facilitators of HIVST across
the literature such as availability of HIVST, privacy &
confidentiality, convenience, and disclosure to serosta-
tus, [25, 26, 41–43] ability of HIVST to decrease stigma
and discrimination, potential of HIVST to circumvent
facility-based barriers, increase confidentiality of HIV
test results after self-testing, and, perceived autonomy
and self-empowerment in decision-making to test were
also found amongst participants in this synthesis [22, 24,
44].
In this synthesis, high costs of self-test kits, the unreli-
ability of self-testing results, low literacy, and fear and
anxiety of positive test results, may mitigate effective
HIVST in different settings in Africa. These findings are
consistent with existing literature on potential barriers
to HIVST globally [41, 44, 45]. For example, there are
mixed views regarding the cost of self-test kits, across
sub-regions of Africa. Since most countries in Africa are
resource-poor, most participants felt that HIVST should
be free of charge subsidized by the government, as the
current conventional HIV testing approaches [25, 43].
While in other settings, some participants were willing
to pay for self-test kits, only if they were ensured of priv-
acy and confidentiality at distribution points for delivery
of self-test kits [22, 41, 43, 46]. However, there is a gap
in the literature on how to achieve free of charge self-
test kits in the for-profit context and calls for empirical
research to fill this gap [27].
The findings from this synthesis highlight that the per-
ceived inability of self-test kits to accurately test for
HIV, and the misinterpretation of test results may
undermine the uptake of self-test kits. Participants
across studies included in this synthesis agreed that in-
formation on how rapid HIV tests function may alleviate
misconceptions, thus improving the uptake of testing
[22, 24].
Irrespective of existing global evidence on potential
benefits of HIVST, [16, 22–25, 41, 43, 47] participants in
this synthesis expressed key concerns related to HIVST,
such as human rights issues, lack of regulatory and qual-
ity assurance systems, low quality of, lack of linkage to
care, and face-to-face counseling. These findings align
with existing literature on HIVST, whereby concerns re-
lated to HIVST were reported. For example, Johnson
and colleagues, [15] agreed that state regulation was an
essential requirement to achieve quality assurance, and
hence promote quality of self-test kits to the advantage
of the users. However, caution was raised regarding state
regulation to restrict access to HIVST, such as setting an
age limit for purchasing test kits, because the purchase
of an HIVST kit was considered to be a personal deci-
sion that should not be interfered by the state [27, 48–
50]. Therefore, it behooves HIV policymakers, and inter-
ventionists to develop country-specific HIVST regulatory
and policy frameworks that focus on safety, prevention
of coercive use, and effectiveness of HIVST [19, 51, 52].
To address the lack of linkage to care and face-to-face
counseling, this synthesis recommends innovative coun-
seling and training approaches for users of HIVST.
Strategies to increase linkage to HIV prevention, care
and treatment after HIVST include home visits or phone
calls, [53] and demand-side financial incentives [54].
Strategies, such as the use of toll-free phone numbers
provided by the manufacturers of HIVST for counseling
have been perceived of greater quality than face-to-face
counseling in different settings [55, 56].
Further research is warranted to evaluate algorithms
and methods that will facilitate adequate linkage to care
following HIVST [19, 51, 52]. However, Gagnon et al.,
[27] caution that such strategies could indirectly propa-
gate stigma by making HIV testing a “clandestine activ-
ity” done in the home settings in secrecy.
This synthesis identified two qualitative studies,
reporting self-testing experiences among adult men
and women in Kenya, Malawi, and South Africa [6,
40]. Participants reported that the availability of
HIVST creates an opportunity for re-initiation of
ART, suggesting that defaulter may be more likely to
prefer HIVST than standard HTS to re-initiate HIV
care and treatment.
Among HIVST users, easy to use of self-test kits and
preference of oral fluid-based HIV rapid test (RDT)
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because it is less invasive and painless was frequently
cited across two studies included in this synthesis. These
findings align with existing literature on HIVST, sug-
gesting that most users (even with low literacy) find
HIVST is easy to use, [57] and may prefer oral fluid-
based HIV RDT to finger stick/ or whole blood-based
HIV [6, 55, 58].
Confusion on how to use self-test kits was cited as the
main cause of user errors and inaccuracy, particularly
with unsupervised HIVST [6]. This observation concurs
with findings among female sex workers in Uganda, [59]
and underlines the need to provide training on HIVST
use, accompanied with clear pictorial instruction-for-use
in local language on how to perform HIVST, easy steps
to interpret the test result, and linkage to support and
counseling services [55, 59–61].
Further, different products of self-test kits with differ-
ent manufacturer’s instruction were cited to increase
rates of wrong interpretation of test results. In consider-
ing new HIVST products, which are under development
and could be adapted for HIVST, caution should be
made to manufacturers to develop user-friendly HIVST
products to reduce the rates of user errors [22, 24].
Strengths and limitation
The strength of this synthesis is based on the systematic
search of multiple databases to identify all relevant quali-
tative studies meeting the predetermined inclusion cri-
teria. Additionally, we included studies using different
methodological approaches, contributing to the in-depth
understanding of HIV stakeholder’s perceptions of the
factors that enable or deter the uptake of HIV self-
testing in Africa. Another strength is the inclusion of
studies conducted among actual users of HIVST, which
provides findings relevant to the research question, as
opposed to studies conducted on hypothetical use of
HIVST.
Studies were not excluded based on the overall ‘low
quality’; so long they contributed relevant qualitative evi-
dence, resulting in a comprehensive review capturing a
range of perspectives to the study objectives. Another
strength was the use of the CASP tool for methodo-
logical quality assessment, [28] and CERQual, for the
confidence of qualitative evidence [29]. The use of these
multiple approaches, had advantages, including the pos-
sibility to reach conclusions based on similarities identi-
fied in heterogeneous studies, more accessibility to a
wider audience than primary studies, and provide a
weight of evidence about HIVST.
There are however some limitations of this synthesis.
Foremost, the possibility that this review might not re-
flect all the barriers, facilitators and actual user’s experi-
ences related to HIVST that are relevant could be a
limitation because of a few studies conducted across
African countries. Most primary studies reported views
of HIV stakeholders about the hypothetical use of
HIVST, which may not reflect their actual practice. Only
two primary studies reported the actual practice of self-
testing among adult users, indicating a need for further
research on HIVST testing experiences across different
populations in Africa. Secondly, there is the possibility
of having missed some publications. To mitigate this
limitation, we scanned references of selected papers for
additional studies. Due to language constraints, we only
included papers published in English, and the findings
reported henceforth may be subject to English language
publication bias.
Conclusions
Generally, the uptake of HIV testing in Africa is a com-
plex process influenced by multifaceted and interlinked
factors. This synthesis contributed to a literature gap on
HIVST by identifying important factors that enable or
deter the uptake of HIVST among adults in Africa.
While identified facilitators of, and barriers to the uptake
of HIVST cut across studies from sub-regions of Africa,
HIVST interventionists should develop context-specific,
culturally appropriate strategies to increase uptake of
HIV testing using HIVST. Actual HIVST users
expressed preference of oral-fluid self-testing because it
is easy to use, less invasive and painless compared to
finger-stick/whole blood-based HIV tests. Lack of clear
instructions on how to use self-test kits, and existing dif-
ferent products of HIVST increases rates of user errors.
If adopted as a complimentary HTS option, HIVST
could facilitate early detection, early care, treatment, and
prevention, and maybe pivotal in providing an invaluable
tool to increase access to HIV care, treatment, and pre-
vention to achieve the 95–95-95 by 2030 [1, 2].
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